Gastroenterologie
a hepatologie

The most common psychiatric disorders in patients with inflammatory bowel disease

Petra Mináriková ^{Orcid.org  1}, Petra Matějková², Martina Hazuková³, Martina Pfeiferová⁴

+ Affiliation
¹ Interní klinika 1. LF UK a ÚVN – VFN, Praha
² ResTrial GastroEndo s.r.o., Praha
³ Edutera z.s., Praha
⁴ Pacientská organizace IBD, Praha

Summary

The article deals with the connections between inflammatory bowel disease (IBD) and psychiatric diseases. It focuses on anxiety and depressive disorders, which are the most common. It outlines current knowledge about the epidemiology of these psychiatric disorders in patients with IBD. It briefly describes the pathophysiological mechanisms. The authors emphasize the advantage of early diagnosis in gastroenterological practices, and offer options for screening methods such as questionnaires for anxiety (GAD-7) and depression (PHQ-9). Although cooperation with psychiatrists and psychotherapists is desirable, gastroenterologists can also treat anxiety and depressive symptoms by themselves. The article mentions the most common psychotherapeutic procedures and pharmacological treatment. The aim of the article is to help gastroenterologists in the diagnosis and treatment of anxiety and depressive disorders in patients with IBD.

Keywords

inflammatory bowel disease, psychiatric disorders

To read this article in full, please register for free on this website.

Benefits for subscribers

Benefits for logged users

Literature

1. Dubinsky MC, Dotan I, Rubin DT et al. Burden of comorbid anxiety and depression in patients with inflammatory bowel disease: a systemic literature review Expert Rev Gastroenterol Hepatol 2021; 15(9): 985–997. doi: 10.1080/17474124.2021.1911644.
2. Fousekis FS, Katsanos AH, Kourtis G et al. Inflammatory bowel disease and patients with mental disorders: what do we know? J Clin Med Res 2021; 13(9): 466–473. doi: 10.14740/jocmr4593.
3. Tarar ZI, Zafar MU, Farooq U et al. Burden of depression and anxiety among patients with inflammatory bowel disease: results of nationwide analysis. Int J Colorectal Dis 2022; 37(2): 313–321. doi: 10.1007/s00384-021-04056-9.
4. Larsen JT, Yilmaz Z, Vilhjalmsson BJ et al. Anorexia nervosa and inflammatory bowel diseases – diagnostic and genetic assotiations. JCCP Adv 2021; 1(4): e12036. doi: 10.1002/jcv2.12036.
5. Askar S, Sakr M, Abd Alaty WH et al. The psychological impact of inflammatory bowel disease as regards anxiety and depression: a single-center study. Middle East Curr Psychiatr 2021; 28(1): 73. doi: 10.1186/s43045-021-00154-0.
6. Ge L, Liu S, Li S et al. Psychological stress in inflammatory bowel disease: psychoneroimmunological insights into biderectional gut-brain communications. Front Immunol 2022; 13: 1016578. doi: 10.3389/fimmu.2022.1016578.
7. Mikocka-Walus A, Massuger W, Knowles SR et al. Psychological distress is highly prevalent in inflammatory bowel disease: a survey of psychological needs and attitudes. JGH Open 2019; 4(2): 166–171. doi: 10.1002/jgh3.12236.
8. Paulides E, Boukema I, van der Woude CJ et al. The effect of psychotherapy on quality of life in IBD patients: a systemic review. Inflamm Bowel Dis 2021; 27(5): 711–723. doi: 10.1093/ibd/izaa144.
9. Graffigna G, Bosio C, Pagnini F et al. Promoting psycho-social wellbeing for engaging inflammatory bowel disease patients in their care: an Italian consensus statement. BMC Psychol 2021; 9(1): 186. doi: 10.1186/s40359-021-00692-6.
10. Neuendorf R, Harding A, Stello N et al. Depression and anxiety in patients with inflammatory bowel disease: a systemic review. J Psychosom Res 2016; 87: 70–80. doi: 10.1016/j.jpsychores.2016.06.001.
11. Umar N, King D, Chandan JS et al. The assotiation between inflammatory bowel disease and mental ill health: a retrospective cohort study using data UK primary care. Aliment Pharmacol Ther 2022; 56(5): 814–822. doi: 10.1111/apt.17110.
12. Hu S, Chen Y, Chen Y et al. Depression and anxiety disorders in patients with inflammatory bowel disease. Front Psychiatry 2021; 12: 714057. doi: 10.3389/fpsyt.2021.714057.
13. Bartocci B, Buono AD, Gabbiadini R et al. Mental illness in inflammatory bowel disease: mens sana in corpore sano. Medicina 2023; 59(4): 682. doi: 10.3390/medicina59040682.
14. Sung KY, Zhang B, Wang HE et al. Schizophrenia and risk of new-onset inflammatory bowel disease: a nationwide longitudinal study. Aliment Pharmacol Ther 2022; 55(9): 1192–1201. doi: 10.1111/apt.16856.
15. Barberio B, Zamani M, Black CJ et al. Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 2021; 6(5): 359–370. doi: 10.1016/S2468-1253(21)00014-5.
16. McNamara J, Wilson W, Pipicella JL et al. The burden of mental health disease in people with inflammatory bowel disease – Crohn‘s Colitis Cure (CCC) data insights program. J Crohns Colitis 2024; 18: i930. doi: 10.1093/ecco-jcc/ jjad212.0592.
17. Lontai L, Elek LP, Balogh F et al. Burden of mental health among patients with inflammatory bowel disease – a cross-sectional study from a tertiary IBD center in Hungary. J Clin Med 2024; 13(7): 2002. doi: 10.3390/jcm13072002.
18. Fracas E, Costantino A, Buoli M et al. Two simple tools for assessing depression and anxiety in patients with inflammatory bowel diseases. J Crohns Colitis 2024; 18(Suppl 1): i2110. doi: 10.1093/ecco-jcc/jjad212.1314.
19. Abautret-Daly A, Dempsey E, Parra-Blanco A et al. Gut-brain actions underlying comorbid anxiety and depression associated with inflammatory bowel disease. Acta Neuropsychiatr 2018; 30(5): 275–296. doi: 10.1017/neu.2017.3.
20. Adamantidis A. How the gut talks to the brain. Science 2022; 376(6590): 248–249. doi: 10.1126/science.abo7933.
21. Zheng P, Zeng B, Zhou C et al. Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host’s metabolism. Mol Psychiatry 2016; 21(6): 786–796. doi: 10.1038/mp.2016.44.
22. Sokol H, Landman C, Seksik P et al. Fecal microbiota transplantation to maintain remission in Crohn‘s disease: a pilot randomized controlled study. Microbiome 2020; 8(1): 12. doi: 10.1186/s40168-020-0792-5.
23. Craig CF, Filippone RT, Stavely R et al. Neuroinflammation as an etiological trigger for depression comorbid with inflammatory bowel disease. J Neuroinflamm 2022; 19(1): 4. doi: 10.1186/s12974-021-02354-1.
24. Nosková E, Stopková P, Šebela A. Aktuální trendy v terapeutickém přístupu u úzkostných poruch. Psychiatr Praxi 2017; 18(3): 106–113. doi: 10.36290/psy.2017.020.
25. Anders M. Týden mozku 2022: Převratný vývoj koncepce vztahu těla a duše. 2022 [online]. Dostupné z: https: //www.tydenmozku.cz/zaznamy/.
26. IsHak WW, Pan D, Steiner AJ et al. Patient-reported outcomes of quality of life, functioning, and GI/psychiatric symptom severity in patients with Inflammatory Bowel Disease (IBD). Inflamm Bowel Dis 2017; 23(5): 798–803. doi: 10.1097/MIB.0000000000001060.
27. Hu S, Chen Y, Chen Y et al. Depression and anxiety disorders in patients with inflammatory bowel disease. Front Psychiatry 2021; 12: 714057. doi: 10.3389/fpsyt.2021.714057.
28. Lenti MV, Cococcia S, Ghorayeb J et al. Stigmatisation and resilience in inflammatory bowel disease. Intern Emerg Med 2020; 15(2): 211–223. doi: 10.1007/s11739-019-02268-0.
29. Lukáš M. Idiopatické střevní záněty II: nové trendy a mezioborové souvislosti. Praha: Grada Publishing 2021.
30. Milo F, Imondi C, D’Amore C et al. Short-term psychodynamic psychotherapy in addition to standard medical therapy increases clinical remission in adolescents and young adults with inflammatory bowel disease: a randomised controlled trial. J Crohns Colitis 2024; 18(2): 256–263. doi: 10.1093/ecco-jcc/ jjad145.
31. Triantafilidis JK, Merikas E, Gikas A. Psychological factors and stress in inflammatory bowel disease. Expert Rev Gastroenterol Hepatol 2013; 7(3): 225–238. doi: 10.1586/ egh.13.4.
32. Riggott C, Mikocka-Walus A, Gracie D et al. Efficacy of psychological therapies in people with inflammatory bowel disease: a systemic review and meta-analysis. Lancet Gastroenterol Hepatol 2023; 8(10): 919–931. doi: 10.1016/S2468-1253(23)00186-3.
33. Byrne G, Rosenfeld G, Leung Y et al. Prevalence of anxiety and depression in patiens with inflammatory bowel disease. Can J Gastroenterol 2017; 2017: 6496727. doi: 10.1155/2017/6496727.
34. Pacienti IBD. 2024 [online]. Dostupné z: https: //www.crohn.cz.
35. Tašková I. Úzkostné poruchy a jejich léčba. Prakt Lek 2021; 17(4): 207–212.
36. Paclt I. Klinická psychofarmakologie. 2024 [online]. Dostupné z: https: //psychiatrie.lf1.cuni.cz/file/6067/paclt-klinicka-psychofarmakologie.pdf.